23Andme Holding Co
23andMe Holding Co. operates as a consumer genetics testing company in the United States, the United Kingdom, Canada, and internationally. The company operates in two segments, Consumer and Research Services, and Therapeutics. The Consumer and Research Services segment provides personal genome service (PGS) that consists of a suite of genetic reports, including information on customers' genetic a… Read more
Market Cap & Net Worth: 23Andme Holding Co (ME)
23Andme Holding Co (NASDAQ:ME) has a market capitalization of $11.96 Million ($11.96 Million) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #28610 globally and #9526 in its home market, demonstrating a -65.55% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying 23Andme Holding Co's stock price $0.61 by its total outstanding shares 19721800 (19.72 Million).
23Andme Holding Co Market Cap History: 2020 to 2025
23Andme Holding Co's market capitalization history from 2020 to 2025. Data shows change from $4.51 Billion to $11.96 Million (-73.55% CAGR).
23Andme Holding Co Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how 23Andme Holding Co's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.29x
23Andme Holding Co's market cap is 0.29 times its annual revenue
0.68x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $4.51 Billion | $305.46 Million | -$289.31 Million | 14.76x | N/A |
| 2021 | $2.63 Billion | $243.92 Million | -$183.36 Million | 10.77x | N/A |
| 2022 | $851.98 Million | $271.89 Million | -$217.49 Million | 3.13x | N/A |
| 2023 | $360.32 Million | $299.49 Million | -$311.66 Million | 1.20x | N/A |
| 2024 | $64.10 Million | $219.64 Million | -$666.70 Million | 0.29x | N/A |
Competitor Companies of ME by Market Capitalization
Companies near 23Andme Holding Co in the global market cap rankings as of March 18, 2026.
Key companies related to 23Andme Holding Co by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #91 globally with a market cap of $176.18 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #154 globally with a market cap of $120.38 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.34 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #512 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #91 | Thermo Fisher Scientific Inc | NYSE:TMO | $176.18 Billion | $470.00 |
| #154 | Danaher Corporation | NYSE:DHR | $120.38 Billion | $191.39 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.34 Billion | $586.37 |
| #512 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
23Andme Holding Co Historical Marketcap From 2020 to 2025
Between 2020 and today, 23Andme Holding Co's market cap moved from $4.51 Billion to $ 11.96 Million, with a yearly change of -73.55%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $11.96 Million | -81.34% |
| 2024 | $64.10 Million | -82.21% |
| 2023 | $360.32 Million | -57.71% |
| 2022 | $851.98 Million | -67.57% |
| 2021 | $2.63 Billion | -41.73% |
| 2020 | $4.51 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of 23Andme Holding Co was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $11.96 Million USD |
| MoneyControl | $11.96 Million USD |
| MarketWatch | $11.96 Million USD |
| marketcap.company | $11.96 Million USD |
| Reuters | $11.96 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.